There are 2949 resources available
Lifestyle factors: From doctor recommendations to daily life
Presenter: Jennifer Ligibel
Session: How can we reduce cancer numbers? (in collaboration with ASCO)
Resources:
Slides
Webcast
The clinical perspective: Trials fit for purpose in 2020 and beyond
Presenter: Irene Braña
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
The regulatory perspective: How to look for certainty in terra incognita
Presenter: Francesco Pignatti
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
The HTA perspective: Is tissue-independent approval the next top model?
Presenter: Sonia Garcia Perez
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
Implementation of NGS diagnostics in the NHS: The example of Belgium
Presenter: Marc Van Den Bulcke
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Christophe Massard
Session: Applications of artificial intelligence (AI) in oncology drug development
Resources:
Webcast
Q&A and live discussion
Presenter: Rebecca Dent
Session: Recent updates in treatment strategies
Resources:
Webcast
Q&A and live discussion
Presenter: Jonathan Strosberg
Session: Peptide Receptor Radionuclide Therapy (PRRT) integration with other therapies
Resources:
Webcast
Q&A and live discussion
Presenter: Rolf Bjerkvig
Session: Blood-brain barrier
Resources:
Webcast
Q&A and live discussion
Presenter: Susana Banerjee
Session: Checkpoint inhibitors and beyond in gynaecological cancers
Resources:
Webcast